Relief Therapeutics Holding SA (ETR:RLF) | Finanzwire

Basculer en Français

11016	Companies
241362	Keywords
169864	Articles
129900	Press releases

Headlines Articles Press releases Relief Therapeutics Holding SA

Home
Companies
Relief Therapeutics Holding SA

BRIEF

published on 10/04/2024 at 07:05, 1 year 11 months ago

Relief Therapeutics Reports Positive Study Results for Phenylketonuria Treatment

Relief Therapeutics RLF-OD032 Phenylketonuria Sapropterin Dihydrochloride Clinical Study Results
PRESS RELEASE

published on 10/04/2024 at 07:00, 1 year 11 months ago

Relief Therapeutics Reports Positive Results from RLF-OD032 Proof-of-Concept Clinical Study for Phenylketonuria
Relief Therapeutics reports positive results from RLF-OD032 proof-of-concept clinical study for Phenylketonuria, showing bioequivalence with KUVAN(R) in managing PKU. RLF-OD032 aims to offer a patient-friendly, portable solution for PKU treatment

Clinical Study Relief Therapeutics RLF-OD032 Bioéquivalence Phenylketonuria
BRIEF

published on 09/23/2024 at 07:05, 1 year 11 months ago

Relief Therapeutics Announces $2 Million Milestone Under Royalty Sales Agreement

FDA Approval Relief Therapeutics Milestone Payment Niemann-Pick Disease SWK Funding
PRESS RELEASE

published on 09/23/2024 at 07:00, 1 year 11 months ago

Relief Therapeutics Announces $2 Million Milestone Under Royalty Sales Agreement
Relief Therapeutics announced $2 million milestone payment under royalty sales agreement after FDA approval of arimoclomol for Niemann-Pick Disease Type C treatment

FDA Approval Relief Therapeutics Milestone Payment Arimoclomol Royalty Sales Agreement

Accesswire

Published on 09/17/2026 at 15:55, 10 minutes ago

Empress Announces Agreement to Acquire Tongon Gold Stream and Secures Debt Financing
Published on 09/17/2026 at 15:25, 40 minutes ago

AIAI Holdings' Constellation Network Launches Dôr Patient Journey with Proactive MD(R), Expanding Transformational AI In Healthcare
Published on 09/17/2026 at 15:00, 1 hour 5 minutes ago

Norsemont Hits 41 Meters of 4.59 g/t Gold as Phase 3 Drilling Continues to Expand the Choquelimpie System
Published on 09/17/2026 at 15:00, 1 hour 5 minutes ago

ECC Ventures 4 Announces Termination of Agreement With Cambria Gold Mines Inc.
Published on 09/17/2026 at 14:50, 1 hour 15 minutes ago

Caldwell Strengthens Human Resources Practice with Addition of Ali Palmer as Partner

View all ACCESSWIRE

EQS Group

Published on 09/17/2026 at 15:30, 34 minutes ago

Huawei Introduces OceanStor M900 Context Memory Storage to Accelerate AI Inference in Hyperscale Data Centers
Published on 09/17/2026 at 15:08, 56 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 09/17/2026 at 15:07, 57 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc
Published on 09/17/2026 at 15:07, 58 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 09/17/2026 at 15:06, 59 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc

Les Echos

Published on 09/16/2026 at 20:46, 19 hours 18 minutes ago

LNA SANTE : 2026 First Half Results
Published on 09/16/2026 at 17:45, 22 hours 20 minutes ago

5th edition of “On the way up” show
Published on 09/16/2026 at 17:45, 22 hours 20 minutes ago

Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 9 hours ago

bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 22 hours ago

Report on the Combined General Meeting of the 10th of September 2026

View all LES ECHOS COMFI WIRE